- Led investing in blockchain infrastructure, cloud services, fintech, DeFi, gaming, delivering annualized net returns of 27% since inception- Developed the operating model for a decentralized edge computing network, defining multi-scenario financial projections- Developed investment thesis used to analyze opportunities for market size/structure, product/market fit, financials - Led all aspects of investor communications, including quarterly letters, investment memoranda, case studies, and investor presentations- Successfully established and managed the compliance and FP&A functions of a master-feeder fund structure optimized for tax efficiencies

- Led advanced materials and chemicals banking in Americas, responsible for developing relationships with corporate and private equity clients- Won mandates to raise venturing funding for clients in semiconductor manufacturing materials and renewable ingredients

- Grew financial consulting firm to 7 figures, advising clients on M&A, strategic finance, corporate strategy; raised $30M+ in venture funding- Led corporate development for agtech client, responsible for deal pipeline, executing M&A, and negotiating strategic partnerships- Developed growth strategy for SaaS client by collaborating with sr. management, product, engineering teams to identify market opportunities, streamline product development processes, and enhance customer acquisition and retention strategies- Led agtech origination effort, securing mandates with public and private companies in SaaS and biotech- Successfully raised $25M Series B financing for a cloud-based SaaS company, including investor targeting, financial modeling, developing long-term growth plan with management, and pitching with management as Acting CFO- Authored and delivered an Investor Day presentation that coincided with a 10% increase in share price within days, ultimately leading to a 31% outperformance relative to the S&P500 over the following month- Supported the CFO in strategic communications with investors and analysts for a publicly listed biotech company, contributing to enhanced market understanding and positive stakeholder engagement

- Managed leading agri-inputs group, responsible for developing relationships with early-stage tech firms and established accounts in China and Germany- Led execution for IPO mandate of an agbiotech company, responsible for developing positioning, industry description, due diligence, valuation, and collaborating with company and other advisors on S-1 registration statement- Led and presented valuation analysis in support of Far Eastern New Century’s $1.1Bn acquisition of M&G’s US assets, including bottoms-up, asset-level valuation using market data and operating assumptions developed with client - Led industry coverage execution for two sell-side mandates, including identifying buyers, working with management on marketing materials, meetings with potential acquirers, and determining potential areas of value creation with strategic buyers- Led execution for buy-side mandate from a leading financial sponsor, responsible for valuation, industry analysis, and collaborating with team of consultants on proposal presented to investment committee- Junior coverage officer for 4 large-cap and 3 mid-cap companies, responsible for assisting in idea generation, coordinating capital markets dialogue, managing financial analyses, and overseeing creation of client materials- Helped initiate coverage on 2 mid-cap companies in which my initiative ultimately secured a CEO dialogue

- Helped originate sell-side role co-advising Platform Specialty Products on $4.2B sale of Arysta business, responsible for developing positioning, process recommendations, identifying buyers, and ability-to-pay analyses- Worked directly with management and other deal advisors in creating marketing materials and carve-out financial models for the sale of Chemours’ three noncore businesses for $695M to strategic acquirers within first year of the company’s spin-off from DuPont

- Led preparation of marketing materials in support of Platform Specialty Products’ acquisitions of Agriphar and Arysta for $3.9B

- Led execution for 5 sell-side and buy-side M&A deals simultaneously and identified winning bidder for Dow AgroSciences’ noncore business

- Worked directly with senior management team on two strategic transactions in smart grid software- Built operating model and detailed sum-of-parts valuation using DCF, comparable companies, precedent transactions

- Developed brand extensions and new publishing ventures, including new publication that generated $2.5M in annual sales

- Developed and presented online and in-store retail strategy recommendations from marketing research studies to senior brand managers

- Applied data science techniques in inferential statistics to identify key drivers of customer satisfaction for Fortune 500 telecom companies

- Prepared weekly sales and forecasted sales reports- Created, priced, and maintained client market research proposals and client studies- Asissted in study execution and data collection